These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11364631)

  • 21. Potential interventions for HIV/AIDS wasting: an overview.
    Abrams DI
    J Acquir Immune Defic Syndr; 2000 Oct; 25 Suppl 1():S74-80. PubMed ID: 11126431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV infection and malnutrition.
    Schwenk A
    Curr Opin Clin Nutr Metab Care; 1998 Jul; 1(4):375-80. PubMed ID: 10565377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Approaches to the AIDS Wasting Syndrome.
    Corcoran C
    Posit Dir News; 1998; 10(2):24-7. PubMed ID: 11365549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Megestrol acetate: promises and pitfalls.
    Farrar DJ
    AIDS Patient Care STDS; 1999 Mar; 13(3):149-52. PubMed ID: 10375262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NIH conference on AIDS wasting syndrome. National Institutes of Health.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1997 Aug; 3(8):42-6. PubMed ID: 11364632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nutrition and HIV infection.
    Salomon J; De TP; Melchior JC
    Br J Nutr; 2002 Jan; 87 Suppl 1():S111-9. PubMed ID: 11895147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of HIV related weight loss.
    Cofrancesco J
    Hopkins HIV Rep; 1999 Jan; 11(1):8-9. PubMed ID: 11366164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV and medical nutrition therapy.
    Young JS
    J Am Diet Assoc; 1997 Oct; 97(10 Suppl 2):S161-6. PubMed ID: 9336581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nutritional alterations associated with HIV infection.
    Kotler DP
    J Acquir Immune Defic Syndr; 2000 Oct; 25 Suppl 1():S81-7. PubMed ID: 11126432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment with nandrolone decanoate and megestrol acetate in HIV-infected men.
    Cuerda C; Zugasti A; Bretón I; Camblor M; Miralles P; García P
    Nutr Clin Pract; 2005 Feb; 20(1):93-7. PubMed ID: 16207650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical trials update in human immunodeficiency virus wasting.
    Muurahainen N; Mulligan K
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):104-11. PubMed ID: 9625392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Weight loss and wasting in patients infected with human immunodeficiency virus.
    Grinspoon S; Mulligan K;
    Clin Infect Dis; 2003 Apr; 36(Suppl 2):S69-78. PubMed ID: 12652374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and treatment of endocrine disorders in the HIV-infected patient.
    Corcoran CP; Grinspoon S
    J Int Assoc Physicians AIDS Care; 1998 Feb; 4(2):10-4, 34. PubMed ID: 11365082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance exercise and oxandrolone for men with HIV-related weight loss.
    Romeyn M; Gunn N
    JAMA; 2000 Jul; 284(2):176; author reply 177. PubMed ID: 10889582
    [No Abstract]   [Full Text] [Related]  

  • 35. Exercise treatment for HIV-associated metabolic and anthropomorphic complications.
    Yarasheski KE; Roubenoff R
    Exerc Sport Sci Rev; 2001 Oct; 29(4):170-4. PubMed ID: 11688790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism.
    Ikizler TA; Cano NJ; Franch H; Fouque D; Himmelfarb J; Kalantar-Zadeh K; Kuhlmann MK; Stenvinkel P; TerWee P; Teta D; Wang AY; Wanner C;
    Kidney Int; 2013 Dec; 84(6):1096-107. PubMed ID: 23698226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anorexia/cachexia in patients with HIV: lessons for the oncologist.
    Von Roenn JH; Knopf K
    Oncology (Williston Park); 1996 Jul; 10(7):1049-56; discussion 1062-4, 1067-8. PubMed ID: 8837121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nutrition and HIV infection: a review and evaluation of the extant knowledge of the relationship between nutrition and HIV infection. Center for Food Safety and Applied Nutrition. Food and Drug Administration.
    Raiten DJ
    Nutr Clin Pract; 1991 Jun; 6(3 Suppl):iii-vii, 1S-94S, A1-D1. PubMed ID: 1906575
    [No Abstract]   [Full Text] [Related]  

  • 39. Soluble tumour necrosis factor alpha receptor 2, a serum marker of resistance to the anabolic actions of growth hormone in subjects with HIV disease.
    Gelato MC; Mynarcik D; McNurlan MA
    Clin Sci (Lond); 2002 Jan; 102(1):85-90. PubMed ID: 11749664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [HIV infection. Dietetic nutritional intervention during the symptomatic phase].
    Johnston S
    Rev Enferm; 1998 Sep; 21(241):13-20. PubMed ID: 9807508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.